Empowering health in vulnerable groups through timely statin use, alcohol recovery support, and cash aid for mothers to build ...

How cholera bacteria from Latin America's WASA lineage used viral defense tools to resist phage attacks, fueling a deadly ...

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that tran ...

Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American Society of Clinical Oncology (ASCO) annual meeting ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the ...

Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical ...

VUNO, a global medical AI company, presented its flagship solution VUNO Med ® –DeepCARS ® at the 2025 National Teaching Institute & Critical Care Exposition (NTI), hosted by ...

As awareness around sustainability and menstrual health grows, more women are making the switch to reusable period products. A recent Intimina survey reveals that 88.22% of respondents use reusable ...

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ® , a novel, non-invasive multi-omics blood test ...

Roy Ratnavel survived a civil war; a political prisoner at age 17 in Sri Lanka. At 18, he moved to Canada, settling in Scarborough. After building a successful career in finance, he later shared his ...

References [1]  Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373–92. [2]  Institute ...